A consortium coordinated by the Luxembourg National Research Fund (FNR), together with partners including LIH and IBBL – Integrated BioBank of Luxembourg as well as the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg, has been successful in Phase 1 of the European Commission’s H2020 programme TEAMING. With the support of international partners, the FNR and the national partners propose to establish a “Centre of Excellence in Digital Health and Personalised Healthcare”. The project – CLINNOVA – is one of only 30 projects to pass Phase 1, out of 208 projects submitted to the Commission.

Digitalisation has the potential to increase the efficiency and transparency in healthcare, as well as to improve the care of patients. Around 10 years ago, the Luxembourgish Government decided on a diversification strategy, which encompasses the life sciences and healthcare domains. The strategic development and the investments in personalised medicine were strong contributors to the expansion of LCSB, as well as to the strengthening of the position of LIH.

In this context, the CLINNOVA consortium is now setting up a strategy for the establishment of a new “Centre of Excellence in Digital Health and Personalised Healthcare” – CLINNOVA. On 26th September 2017 was the official kick-off meeting of the consortium and various stakeholders in the endeavor. Present at the meeting was Luxembourg’s Minister of Health, Mrs Lydia Mutsch, as well as representatives from ministries, hospitals, industry and research, as well as representatives from the international partners. The latter are the University of Southern Denmark (SDU) and the Odense University Hospital (OUH) that will allow the consortium to benefit from the experience Denmark has in setting up modern eHealth infrastructures, and the National Centre for Tumour Diseases (NCT) of the German Cancer Research Centre (DKFZ) having strong expertise in oncology.

The Centre will aim to build on the previous investments into fundamental biomedical research and form a bridge to the hospitals in Luxembourg, ensuring that laboratory innovations reach clinical implementation and benefit patients. Having passed phase 1 of H2020 TEAMING, CLINNOVA has received funding from the EU Commission to develop a sound business plan for the phase 2 proposal. If the project is also successful in this phase, financial support will be awarded by H2020 to make CLINNOVA a reality.

Read more

Boosting public-private R&D


Stimulating innovation and research partnerships is becoming a key priority for Luxembourg R&D funding. Companies cooperating with research centres can receive an additional financial injection, and sector-related calls stimulate public-private partnerships using Luxembourg as a testbed for innovative products.
Read more

Developing technology for industry


Supporting businesses with their R&D projects and helping them speed up prototyping and market introduction is central for the Luxembourg Institute of Science and Technology (LIST). LIST’s Sustainable Biotech Innovation Centre cooperates with companies on their development of bio-based products and bioprocesses.
Read more

Call to all Cluster 1 and Cluster 6 coordinators writing a two-stage proposal


Bridge2HE is organising Full Proposal Check events for Cluster 1 and Cluster 6 second-stage proposals with a deadline in September 2022. The events will take place online, in the week between 25 & 29 July 2022.
Read more

“Making supercomputing accessible to all companies”


Luxembourg’s supercomputer MeluXina is among the 40 most powerful systems in the world. It is also unique in its strong focus on value to businesses. We spoke to Senior Solution Engineer Luis Vela at LuxProvide about solutions and services available for clients that want to harness the full power of data.
Read more

Luxembourg to set up health technologies campus


The campus, which is expected to open its doors in 2024, will be dedicated to digital health and personalised medicine.
Read more

All news